52 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 29589062 | N-Acetyltransferase-2 (NAT2) phenotype is influenced by genotype-environment interaction in Ethiopians. | 2018 Jul | 1 |
2 | 30564082 | Study of correlation between the NAT2 phenotype and genotype status among Greenlandic Inuit. | 2018 | 1 |
3 | 27223070 | Differential association for N-acetyltransferase 2 genotype and phenotype with bladder cancer risk in Chinese population. | 2016 Jun 28 | 1 |
4 | 27509179 | Heritability of Caffeine Metabolism: Environmental Effects Masking Genetic Effects on CYP1A2 Activity but Not on NAT2. | 2016 Dec | 2 |
5 | 27582327 | The Effect of Yokukansan, a Traditional Herbal Preparation Used for the Behavioral and Psychological Symptoms of Dementia, on the Drug-Metabolizing Enzyme Activities in Healthy Male Volunteers. | 2016 | 1 |
6 | 26192006 | Caffeine Consumption Contributes to Skin Intrinsic Fluorescence in Type 1 Diabetes. | 2015 Oct | 1 |
7 | 26239303 | In-depth analysis of the critical genes and pathways in colorectal cancer. | 2015 Oct | 1 |
8 | 21480221 | Cytochrome P4501A2 phenotype and bladder cancer risk: The Shanghai bladder cancer study. | 2012 Mar 1 | 1 |
9 | 22686318 | N-Acetyltransferase 2 and glutathione s-transferase M1 in colon and rectal cancer cases from an industrialized area. | 2012 | 1 |
10 | 20801937 | N-Acetyltransferase-2 (NAT2) gene polymorphisms and enzyme activity in Serbs: unprecedented high prevalence of rapid acetylators in a White population. | 2011 Jul | 1 |
11 | 21684175 | alcohol, smoking, and caffeine in relation to fecundability, with effect modification by NAT2. | 2011 Nov | 1 |
12 | 20723593 | Liu wei di huang wan, a well-known traditional Chinese medicine, induces CYP1A2 while suppressing CYP2A6 and N-acetyltransferase 2 activities in man. | 2010 Oct 28 | 1 |
13 | 18704388 | Mesalazine pharmacokinetics and NAT2 phenotype. | 2009 Jan | 1 |
14 | 19082994 | Phenotyping of N-acetyltransferase type 2 and xanthine oxidase with caffeine: when should urine samples be collected? | 2009 Apr | 5 |
15 | 19519341 | Caffeine metabolic ratios for the in vivo evaluation of CYP1A2, N-acetyltransferase 2, xanthine oxidase and CYP2A6 enzymatic activities. | 2009 May | 4 |
16 | 18569594 | N-acetyltransferase-2 and medical history in bladder cancer cases with a suspected occupational disease (BK 1301) in Germany. | 2008 | 1 |
17 | 17011540 | Concordance between the deduced acetylation status generated by high-speed: real-time PCR based NAT2 genotyping of seven single nucleotide polymorphisms and human NAT2 phenotypes determined by a caffeine assay. | 2007 Feb | 2 |
18 | 17344941 | Differential alteration of drug-metabolizing enzyme activities after cyclophosphamide/adriamycin administration in breast cancer patients. | 2007 Jan-Feb | 2 |
19 | 16003747 | NAT2 slow acetylation and bladder cancer in workers exposed to benzidine. | 2006 Jan 1 | 1 |
20 | 16405939 | CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers. | 2006 Jun 15 | 1 |
21 | 16782969 | Stillbirth and slow metabolizers of caffeine: comparison by genotypes. | 2006 Aug | 2 |
22 | 16103443 | A phase I study of indole-3-carbinol in women: tolerability and effects. | 2005 Aug | 1 |
23 | 14747882 | Phenotyping of N-acetyltransferase type 2 by caffeine from uncontrolled dietary exposure. | 2004 Mar | 8 |
24 | 14976127 | Low CYP1A2 activity associated with testicular cancer. | 2004 Jun | 1 |
25 | 15110095 | CYP1A2 and NAT2 genotype/phenotype relations and urinary excretion of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in a human dietary intervention study. | 2004 Jun | 1 |
26 | 12580991 | Interaction of ibuprofen and probenecid with drug metabolizing enzyme phenotyping procedures using caffeine as the probe drug. | 2003 Feb | 1 |
27 | 11875368 | Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas. | 2002 Mar | 1 |
28 | 12008149 | Stability of 5-acetamido-6-formylamino-3-methyluracil in buffers and urine. | 2002 May 15 | 1 |
29 | 12397635 | Orofacial clefts and spina bifida: N-acetyltransferase phenotype, maternal smoking, and medication use. | 2002 Nov | 1 |
30 | 11292476 | Validity of an ELISA for N-acetyltransferase-2 (NAT2) phenotyping. | 2001 May 1 | 1 |
31 | 11393735 | Extractionless method for the simultaneous high-performance liquid chromatographic determination of urinary caffeine metabolites for N-acetyltransferase 2, cytochrome P450 1A2 and xanthine oxidase activity assessment. | 2001 May 5 | 5 |
32 | 11603126 | N-acetyltransferase 2 phenotype in painters with bladder cancer and controls. | 2001 Sep | 1 |
33 | 10718779 | The effect of NAT2 genotype and gender on the metabolism of caffeine in nonsmoking subjects. | 2000 Mar | 1 |
34 | 10027663 | Xanthine oxidase inhibition by allopurinol affects the reliability of urinary caffeine metabolic ratios as markers for N-acetyltransferase 2 and CYP1A2 activities. | 1999 Jan | 2 |
35 | 10744128 | Distribution and concordance of N-acetyltransferase genotype and phenotype in an American population. | 1999 Aug | 1 |
36 | 11253312 | [Phenotyping of cytochrome P-450 1A2 and N-acetyltransferase (NAT2) using the in vivo caffeine test as a tool for determining individual susceptibility to selected xenobiotics]. | 1999 | 2 |
37 | 9525538 | Rate of caffeine metabolism and risk of spontaneous abortion. | 1998 Mar 1 | 1 |
38 | 9565293 | Genotype and phenotype of N-acetyltransferase 2 (NAT2) polymorphism in patients with contact allergy. | 1998 Apr | 1 |
39 | 9123684 | [Clinical relevance of acetylator phenotyping in 196 urothelial tumor patients]. | 1997 Jan | 1 |
40 | 9891107 | N-Acetyltransferase 2 (NAT2) and Glutathione S-Transferase ยต (GSTM1) in Bladder-cancer Patients in a Highly Industrialized Area. | 1997 Apr | 1 |
41 | 11596199 | [Determination of caffeine metabolite for the evaluation of N-acetyltransferase, CYP1A2 and xanthine oxidase activities]. | 1997 Nov | 1 |
42 | 8689813 | N-acetyltransferase 2 polymorphism in patients infected with human immunodeficiency virus. | 1996 Jul | 1 |
43 | 8833625 | Correspondence re: S. H. McQuilkin et al., analysis of within-subject variation of caffeine metabolism when used to determine cytochrome P4501A2 and N-Acetyltransferase-2 activities. Cancer Epidemiol., Biomarkers & Prev., 4: 139-146, 1995. | 1996 Mar | 1 |
44 | 8866914 | Caffeine as a metabolic probe: NAT2 phenotyping. | 1996 Mar | 3 |
45 | 8923605 | Occupational history and genetic N-acetyltransferase polymorphism in urothelial cancer patients of Leverkusen, Germany. | 1996 Oct | 3 |
46 | 9156694 | Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations. | 1996 Apr | 4 |
47 | 7586210 | Lower levels of urinary 2-amino-3,8-dimethylimidazo[4,5-f]-quinoxaline (MeIQx) in humans with higher CYP1A2 activity. | 1995 Nov | 1 |
48 | 7742721 | Analysis of within-subject variation of caffeine metabolism when used to determine cytochrome P4501A2 and N-acetyltransferase-2 activities. | 1995 Mar | 2 |
49 | 7828378 | Low CYP1A2 activity in rural Shona children of Zimbabwe. | 1995 Jan | 1 |
50 | 7920698 | Acetylator phenotyping: the urinary caffeine metabolite ratio in slow acetylators correlates with a marker of systemic NAT1 activity. | 1994 Jun | 1 |